课题基金 / 基金详情

Therapeutic Window for Acute Stroke Therapy

Therapeutic Window for Acute Stroke Therapy
急性中风治疗的治疗窗口
批准号:
6749550
负责人:
Patrick D Lyden
金额:
$119.42万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-05-19 至 2008-04-30

项目摘要

项目成果

Patrick D Lyden的其他基金

相似基金

相关文献

中文摘要
翻译
我们提议在加州大学圣地亚哥分校卒中中心(UCSD)设立急性卒中转化研究专业项目(SPOTRIAS)。核心设施和项目将达到SPOTRIAS的目标,增加溶栓治疗患者的数量,特别是卒中后2小时内治疗的患者。为了实现这一目标,我们提供了4个相互关联的项目。1)为了寻找一种简单的急性脑卒中的血清标志物,我们将描述急性脑卒中患者游离脂肪酸(FFA)的反应,包括时间过程。我们将确定FFA水平是否与各种卒中结果相关,并尝试区分缺血和常见的模拟。我们将描述与有效溶栓相关的FFA反应。2)在1期临床试验中,通过研究中风发作后3 - 6小时开始溶栓,并结合24小时血管内冷却,利用低温延长溶栓时间窗口。我们假设低温对这类患者是安全的。我们将继续进行2期试验,以证明低温降低出血率并改善3至6小时溶栓患者的预后。3)采用无创床边试验——经颅超声造影增强检测溶栓前后血管闭塞和灌注缺陷。我们将测试超声是否可以将卒中与模拟卒中区分开来,并从2小时内出现轻度或波动性缺陷的患者中确定潜在的治疗候选者。4)确定是否新颖的宽带无线上网
英文摘要
We propose a Specialized Program of Translational Research in Acute Stroke (SPOTRIAS) at the University of California, San Diego, Stroke Center (UCSD). The Core facilities and projects will meet SPOTRIAS target goals, increasing the number of thrombolytic-treated patients, particularly those treated within 2 hours following stroke. To achieve this, we offer 4 inter-related projects. 1) To find a simple, serum marker of acute stroke, we will characterize the free fatty acid (FFA) response in acute stroke patients, including the time course. We will determine whether FFA levels correlate with various stroke outcomes, and attempt to distinguish ischemia from common mimics. We will characterize the FFA response associated with effective thrombolysis. 2) To use hypotherrnia to prolong the time window for thrombolysis in a Phase 1 trial, by studying thrombolysis beginning 3 to 6 hours following stroke onset, combined with 24 hours of intravascular cooling. We hypothesize that hypothermia will be safe in such patients. We will proceed to a Phase 2 trial to show that hypothermia reduces hemorrhage rates and improves outcomes in 3 to 6 hour thrombolysis patients. 3) To use a non-invasive, bedside test---contrast enhanced transcranial ultrasoundmto identify vascular occlusion and perfusion defects before and after thrombolysis. We will test whether ultrasound may separate stroke from mimics, and identify potential treatment candidates from among patients with mild or fluctuating deficits presenting within 2 hours. 4) To determine whether novel broadband wireless Internet technology will allow UCSD Stroke Team faculty to direct thrombolysis at remote hospitals by placing audio/video consultation capability at remote Emergency Departments in San Diego. Acute consults may increase the number of 2-hour thrombolytic treatments. These projects are built on the core facilities of the UCSD Stroke Center, which include a nationally recognized stroke team, a training program, a data collection and statistical analysis unit, and a specimen collection and storage facility. All of the needed teams, collaborations, and facilities are in place. The SPOTRIAS program will allow us to enhance and initiate translational research that ultimately will benefit stroke patients by treating more patients under 2 hours, and finding ways to treat additional patients later.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The NIH SPAN Coordinating Center
  • 批准号:
    10591751
  • 项目类别:
  • 资助金额:
    $100.85万
  • 财政年份:
    2023
  • 负责人:
    Patrick D Lyden
  • 依托单位:
ZZ-3K3A-301: A multicenter, randomized, placebo-controlled, double-blinded, Phase 3 study to evaluate the efficacy and safety of 3K3A-APC (RHAPSODY-2)
  • 批准号:
    10305528
  • 项目类别:
  • 资助金额:
    $398.01万
  • 财政年份:
    2022
  • 负责人:
    Patrick D Lyden
  • 依托单位:
The NIH SPAN Coordinating Center
  • 批准号:
    10074917
  • 项目类别:
  • 资助金额:
    $16.7万
  • 财政年份:
    2020
  • 负责人:
    Patrick D Lyden
  • 依托单位:
The NIH SPAN Coordinating Center
  • 批准号:
    10224355
  • 项目类别:
  • 资助金额:
    $78.29万
  • 财政年份:
    2019
  • 负责人:
    Patrick D Lyden
  • 依托单位:
海外基金